Literature DB >> 29772330

Translation and Validation of the Brazilian-Portuguese Short Version of Vascular Quality of Life Questionnaire in Peripheral Artery Disease Patients with Intermittent Claudication Symptoms.

Marilia de Almeida Correia1, Aluísio Andrade-Lima2, Paulo Longano Mesquita de Oliveira3, Rômulo Martins Domiciano3, Wagner Jorge Ribeiro Domingues4, Nelson Wolosker3, Pedro Puench-Leão2, Raphael Mendes Ritti-Dias5, Gabriel Grizzo Cucato6.   

Abstract

BACKGROUND: The Vascular Quality of Life Questionnaire (VascuQoL-6) was proposed to evaluate specific quality of life of peripheral artery disease (PAD) patients. However, there is no Brazilian-Portuguese version available, blunting its use in Brazilian patients. The objective of the study was to analyze the psychometric properties of a translated Brazilian-Portuguese version of VascuQoL-6 in Brazilian patients with PAD with intermittent claudication symptoms.
METHODS: One hundred eleven patients with PAD participated in the study. After translation and retranslation, construct validity was analyzed by identifying correlation between VascuQoL-6 scores, general World Health Organization qualify of life (WHOQOL) score, and subjective and objective functional capacity tests. To determine the reliability, internal consistency and test-retest reliability with at least 7 days interval between 2 questionnaire applications were calculated.
RESULTS: Significant correlations between the VascuQoL-6 score and total WHOQOL score (r = 0.44; P < 0.05) were observed. Moreover, we observed negative correlations between the VascuQoL-6 score and 4-meter usual pace (r = -0.33; P < 0.05) and 4-meter fast pace (r = -0.34; P < 0.05) and positive correlation with onset claudication distance (r = 0.39; P < 0.05) and total walking distance (r = 0.29; P ≤ 0.05). Internal consistency was 0.84, whereas the intraclass coefficient correlation was 0.84, with no differences in VascuQoL-6 scores between the 2 applications days.
CONCLUSIONS: The Brazilian-Portuguese version of the VascuQoL-6 presents adequate valid and reliability indicators, allowing its use in patients with PAD with intermittent claudication symptoms.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29772330     DOI: 10.1016/j.avsg.2018.02.026

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  3 in total

1.  WalkingPad protocol: a randomized clinical trial of behavioral and motivational intervention added to smartphone-enabled supervised home-based exercise in patients with peripheral arterial disease and intermittent claudication.

Authors:  Ivone Silva; Susana Pedras; Rafaela Oliveira; Carlos Veiga; Hugo Paredes
Journal:  Trials       Date:  2022-04-18       Impact factor: 2.728

2.  Effects of arm-crank exercise on cardiovascular function, functional capacity, cognition and quality of life in patients with peripheral artery disease: Study protocol for a randomized controlled trial.

Authors:  Hélcio Kanegusuku; Marília Almeida Correia; Paulo Longano; Raphael Mendes Ritti-Dias; Nelson Wolosker; Gabriel Grizzo Cucato
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

3.  Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study.

Authors:  Heloisa Amaral Braghieri; Marília de Almeida Correia; Juliana Ferreira de Carvalho; Paulo Longano; Nelson Wolosker; Gabriel Grizzo Cucato; Raphael Mendes Ritti-Dias; Hélcio Kanegusuku
Journal:  J Vasc Bras       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.